Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allergic rhinoconjunctivitis: current therapy

H M Hollingsworth1

  • 1Boston University, USA.

Hospital Practice (1995)
|June 15, 1996
PubMed
Summary

Seasonal allergic rhinoconjunctivitis treatments offer many options for symptom relief. This review covers oral, intranasal, and ophthalmic medications, detailing their pros, cons, and optimal use for effective management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lethargy, confusion, and a mediastinal abnormality in a 68-year-old woman.

Chest·1994
Same author

Aspergillus brain abscess complicating allergic Aspergillus sinusitis.

The Journal of allergy and clinical immunology·1994
Same author

Persistent bilateral effusions and fever in a 48-year-old man.

Chest·1993
Same author

Acute respiratory failure in pregnancy.

Clinics in chest medicine·1992
Same author

Effect of triiodothyronine-induced thyrotoxicosis on airway hyperresponsiveness.

Journal of applied physiology (Bethesda, Md. : 1985)·1991
Same author

Wheezing and stridor.

Clinics in chest medicine·1987

Area of Science:

  • Allergy and Immunology
  • Ophthalmology
  • Pharmacology

Background:

  • Seasonal allergic rhinoconjunctivitis (SARC) significantly impacts quality of life.
  • A wide range of therapeutic options are available for SARC management.

Purpose of the Study:

  • To review the advantages and disadvantages of available SARC medications.
  • To guide the prescription and combination of oral, intranasal, and ophthalmic therapies.
  • To discuss strategies for managing side effects and patient preferences in SARC treatment.

Main Methods:

  • Literature review of current therapeutic agents for SARC.
  • Analysis of efficacy, safety profiles, and administration routes of medications.
  • Discussion of clinical considerations for personalized SARC management.

Main Results:

  • Oral, intranasal, and ophthalmic medications each offer distinct benefits and drawbacks.
  • Combinatorial approaches can enhance symptom control for severe SARC.
  • Strategies exist to mitigate side effects and align treatment with patient preferences.

Conclusions:

  • Effective management of SARC involves careful selection and combination of available pharmacotherapies.
  • Personalized treatment plans are crucial for optimizing outcomes and patient satisfaction.
  • Even severe SARC symptoms can be controlled through judicious therapeutic choices.

Related Experiment Videos